Shoulder Innovations, Inc.

SI Healthcare Medical Devices

Shoulder Innovations, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $47.3 million, up 49.6% from fiscal 2024.

Revenue
+37.7%
EPS
+46.9%
Free cash flow
+38.6%
Total debt
0.00%

Quarter to September 2026, against a year earlier

20.29 0.08 −0.39%
Market cap
$424.1M
P/E
0.0×
Fwd P/E
−10.2×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−2.42
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+6 more quarters

0.00 0.00 0.00 0.00
P/S ratio
2.62 5.57 7.00 6.11
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(14.12) (24.28) (56.89) (61.63)
P/B ratio
0.88 2.26 3.38 3.33
EV/Sales
0.31 3.83 5.60 4.91
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(0.41) (4.72) (7.14) (7.41)
Current Ratio
11.07 11.81 10.71 10.68
Net Debt/EBITDA
14.67 12.01 9.51 12.02
Debt/Equity
0.11 0.11 0.12 0.13
Earnings Yield
(1,529.23%) (1,149.07%) (9.47%) (8.57%)
Free Cash Flow Yield
(29.04%) (14.59%) (11.19%) (10.83%)
Free Cash Flow per Share
(1.28) (0.73) (0.46) (0.33)
Book value per Share
16.23 6.44 6.00 5.68
Free Cash Flow
(11.06) (15.09) (9.55) (6.98)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026